HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

GSK Launches Campaign To Help Germans Use OTC Drugs Correctly

Executive Summary

More than 50% of Germans do not use OTC medicines correctly, research by GSK Consumer Healthcare shows. To address this, the firm is launching an awareness raising campaign under the banner “Bewusst richtig handeln.”

You may also be interested in...



GSCF World Congress: Environmental Sustainability In Consumer Health

The third session on day one of the GSCF's World Congress 2022 focused on sustainability and featured contributions from Haleon, Bayer, AESGP, and the UN.

HBW Insight’s Key Takeaways From 2021: #2 Get Serious About Sustainability

In 2021 the consumer health industry ramped up its sustainability efforts, with many firms publishing ambitious “net zero” transition strategies. As 2022 gets underway, recyclable or reusable packaging and consumer behavior change stand out as priority areas for further work, alongside carbon emissions reduction. To counter potential accusations of “greenwashing,” companies must be truthful and transparent about their ESG progress.

Prestige Expands UK Eye Care Range In Response To Consumer Demand

A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151885

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel